BusinessImmuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)By Nasdaq OMXJan 31, 2018, 2:30 PM UTC
BusinessSteraMist™ Contributes to Substantial Reduction in Clostridium Difficile Burden in HospitalBy Nasdaq OMXApr 3, 2017, 8:05 PM UTC
BusinessParatek Presents Data from Omadacycline Clinical Development Program at ECCMIDBy Nasdaq OMXApr 11, 2016, 11:30 AM UTC
BusinessParatek Presents Pre-Clinical Data on the Effects of Omadacycline on Clostridium DifficileBy Nasdaq OMXApr 11, 2016, 11:30 AM UTC
